Kofol SF Syrup

Indications

• Cough
• Bronchitis
• Asthma
• Respiratory tract infections
• Inflammatory conditions

Dosage

Children: Refer to established guidelines or consult a healthcare professional for appropriate dosing.

Adults: Refer to established guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

The primary active components of Adhatoda, particularly vasicine and vasicinone, exhibit bronchodilator effects by relaxing the bronchial smooth muscles. They also act as mucolytics, facilitating the clearance of mucus from the respiratory tract. Furthermore, these compounds have been shown to exert anti-inflammatory effects by inhibiting the release of pro-inflammatory cytokines and mediators. This multi-faceted mechanism makes Adhatoda effective in alleviating symptoms associated with respiratory ailments.

Pharmacodynamics

Adhatoda demonstrates a range of pharmacodynamic effects, including bronchodilation, mucus secretion modulation, and anti-inflammatory action. The alkaloids enhance ciliary action in the respiratory tract, improving mucus clearance. The anti-inflammatory properties reduce airway inflammation, which is beneficial in conditions such as asthma and chronic bronchitis. Additionally, the antimicrobial activity of Adhatoda may help in preventing secondary infections in respiratory diseases.

Pharmacokinetics

The pharmacokinetics of Adhatoda have not been extensively studied. However, it is known that the active compounds are absorbed after oral administration, with effects typically observed within hours. The metabolic pathways of vasicine and other alkaloids involve hepatic metabolism, and they are likely excreted in urine. The bioavailability and half-life of these compounds require further investigation to establish precise pharmacokinetic profiles.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Dizziness
• Headache
• Skin rash

Interactions

• May interact with anticoagulants, increasing the risk of bleeding
• Potential interaction with antihypertensive medications

Precautions

• Use with caution in patients with a history of gastrointestinal disorders
• Should be used cautiously in patients with liver disease
• Monitor for potential allergic reactions

Pregnancy

Ahdatoda should be used cautiously during pregnancy. Consultation with a healthcare provider is recommended.

Breast-feeding

Safety during breastfeeding has not been established; consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Dried leaves
• Powdered form
• Extracts

Indications

• Inflammatory conditions
• Cancer prevention and treatment
• Antioxidant therapy
• Digestive disorders
• Cardiovascular health

Dosage

Children: Refer to the BNF for Children for appropriate pediatric dosing recommendations.

Adults: Refer to the BNF for specific dosing guidelines, as dosages can vary based on the formulation and clinical indication.

Mechanism of action

Curcumin acts as a scavenger of reactive oxygen species, including hydroxyl radicals and superoxide anions, and inhibits lipid peroxidation as well as peroxide-induced DNA damage. It exhibits potent anti-inflammatory and anti-carcinogenic effects by modulating various signaling molecules. Curcumin inhibits protein kinases, c-Jun/AP-1 activation, and cyclooxygenase (COX)-2 activity, impacting cellular signal transduction pathways related to growth and malignant transformation.

Pharmacodynamics

In experimental animal models, curcumin has demonstrated significant pharmacological effects, such as increasing bile flow and inhibiting inflammation and edema formation. It has been shown to decrease cell proliferation and promote apoptosis in cancer cells. Additionally, curcumin inhibits platelet aggregation induced by arachidonic acid, suggesting its role in cardiovascular health.

Pharmacokinetics

Curcumin's pharmacokinetics are characterized by low bioavailability due to rapid metabolism and systemic elimination. It undergoes extensive hepatic metabolism, leading to the production of several metabolites. The absorption of curcumin can be enhanced by co-administration with piperine. Oral bioavailability remains a challenge, which has led to the exploration of various formulations to improve its therapeutic efficacy.

Adverse effects

• Gastrointestinal disturbances
• Nausea
• Diarrhea
• Allergic reactions

Interactions

• May enhance the effects of anticoagulants
• Potential interaction with antidiabetic medications
• May interfere with the metabolism of certain drugs due to inhibition of cytochrome P450 enzymes

Precautions

• Use with caution in patients with gallbladder disease
• Monitor patients on anticoagulant therapy
• Caution in patients with diabetes due to potential hypoglycemic effects

Pregnancy

Safety during pregnancy has not been established, caution is advised.

Breast-feeding

Curcumin may be excreted in breast milk, caution is advised.

Storage

Store in a cool, dry place away from light.

Formulations

• Powder
• Capsules
• Tablets
• Liquid extracts

Indications

• Gastrointestinal disorders (e.g., peptic ulcers, dyspepsia)
• Respiratory conditions (e.g., cough, bronchitis)
• Inflammatory conditions (e.g., arthritis, dermatitis)
• Viral infections (e.g., hepatitis, herpes simplex)

Dosage

Children: Refer to established clinical guidelines for appropriate dosing, as no specific dose is provided.

Adults: Refer to established clinical guidelines for appropriate dosing, as no specific dose is provided.

Mechanism of action

Glycyrrhizin, the active compound in glabra, inhibits the enzyme 11β-hydroxysteroid dehydrogenase type 2, leading to increased cortisol levels in tissues. This mechanism helps to reduce inflammation and modulate immune responses. Additionally, glabra exhibits antiviral activity by inhibiting the replication of certain viruses, possibly through interference with viral proteins and host cell interactions.

Pharmacodynamics

The pharmacodynamic effects of glabra are primarily attributed to glycyrrhizin and flavonoids present in the plant. Its anti-inflammatory effects are mediated through the inhibition of pro-inflammatory cytokines and pathways such as NF-κB. The compound also has expectorant properties, aiding in the relief of cough and respiratory distress by promoting mucus secretion and reducing irritation in the airways.

Pharmacokinetics

Glycyrrhizin is absorbed in the gastrointestinal tract, and its bioavailability can be influenced by the presence of other food components. Once absorbed, it undergoes hepatic metabolism, with its metabolites excreted primarily through urine. The half-life of glycyrrhizin can vary but is generally several hours, necessitating multiple doses for sustained therapeutic effects. Chronic use may lead to accumulation and potential side effects such as hypertension and hypokalemia due to its mineralocorticoid-like effects.

Pregnancy

The safety of glabra during pregnancy has not been established. It is advisable to avoid its use unless clearly needed.

Breast-feeding

There is limited information on the excretion of glabra in human milk. Caution is advised when administering to breastfeeding mothers.

Storage

Store at room temperature, away from moisture and direct light. Keep out of reach of children.

Indications

• Adrenal insufficiency
• Chronic inflammatory conditions

Mechanism of action

Glycyrrhizin, the primary active component of Glycyrrhiza, exerts its effects primarily through inhibition of the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2). This inhibition prevents the conversion of active cortisol to inactive cortisone, leading to increased cortisol levels. Elevated cortisol mimics the effects of aldosterone, resulting in sodium retention, potassium excretion, and increased blood pressure. Additionally, licorice has anti-inflammatory and antiviral properties attributed to its ability to modulate various immune pathways and inhibit viral replication.

Pharmacodynamics

The pharmacodynamic effects of Glycyrrhiza include anti-inflammatory, antiviral, and immunomodulatory activities. Glycyrrhizin has been shown to reduce inflammation by inhibiting the production of pro-inflammatory cytokines and mediators. Its potential antiviral properties are particularly noted in viral infections such as hepatitis C and COVID-19, where it may inhibit viral replication. Furthermore, its ability to enhance the effects of corticosteroids can be beneficial in treating conditions associated with adrenal insufficiency or chronic inflammation.

Pharmacokinetics

Glycyrrhizin is absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 1-2 hours after oral administration. It undergoes extensive metabolism in the liver, primarily through conjugation processes, leading to the formation of glycyrrhetic acid as a major metabolite. The elimination half-life of glycyrrhizin is approximately 6-8 hours. Glycyrrhiza components are excreted in urine predominantly as conjugated forms. Long-term use can lead to accumulation and potential side effects due to its mineralocorticoid-like effects.

Contra-indications

• Hypertension
• Hypokalemia
• Severe kidney disease
• Pregnancy (due to hormonal effects)

Adverse effects

• Hypertension
• Hypokalemia
• Edema
• Headaches
• Fatigue
• Muscle weakness
• Cardiac arrhythmias (with excessive use)

Interactions

• May enhance the effects of corticosteroids
• May increase the risk of hypokalemia with diuretics
• May interact with anticoagulants, increasing the risk of bleeding
• May affect the metabolism of drugs metabolized by CYP3A4

Precautions

• Use with caution in patients with cardiovascular disease
• Monitor blood pressure and potassium levels during prolonged use
• Not recommended for long-term use without medical supervision

Pregnancy

Glycyrrhiza should be avoided during pregnancy as it may cause hormonal effects that could affect fetal development.

Breast-feeding

Consult a healthcare provider before use while breastfeeding, as safety is not well established.

Storage

Store in a cool, dry place, away from direct sunlight and moisture.

Formulations

• Dried root
• Extracts (liquid and powdered)
• Teas
• Capsules

Indications

• Anxiety
• Insomnia
• Nutritional supplement
• Antioxidant support
• Immune system support

Dosage

Children: Refer to authoritative sources for specific dosing information.

Adults: Refer to authoritative sources for specific dosing information.

Mechanism of action

The mechanism of action of Longan is not fully elucidated, but it is believed to exert its effects through the modulation of neurotransmitters, particularly influencing serotonin and gamma-aminobutyric acid (GABA) pathways. The fruit is rich in antioxidants, which may contribute to its protective effects against oxidative stress.

Pharmacodynamics

Longan is known for its high content of vitamins, minerals, and antioxidants, including vitamin C, B vitamins, and polyphenols. These compounds may enhance immune function, promote nervous system health, and improve skin health. Its calming effects may be attributed to constituents that influence neurotransmitter activity.

Pharmacokinetics

The pharmacokinetics of Longan is not well-studied, but as a food source, it is likely to be absorbed through the gastrointestinal tract. The bioavailability of its active compounds may vary depending on preparation methods (fresh, dried, or processed). The metabolism and excretion pathways are not clearly defined in the literature.

Pregnancy

Insufficient data on the safety of longa during pregnancy. Consult a healthcare provider before use.

Breast-feeding

Insufficient data on the excretion of longa in human milk. Caution is advised when using during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Irritable bowel syndrome (IBS)
• Diarrhea
• Constipation
• Gut dysbiosis
• Support for immune function
• Enhancement of gut health

Dosage

Adults: Refer to specific product guidelines and consult a healthcare professional for dosing recommendations, as doses can vary based on formulation and intended

Mechanism of action

Bifidobacterium longum exerts its beneficial effects primarily through the modulation of the gut microbiota. It helps in the fermentation of dietary fibers, producing short-chain fatty acids (SCFAs) that nourish colon cells and maintain gut barrier integrity. Moreover, it competes for adhesion sites and nutrients against pathogenic bacteria, thereby inhibiting their growth. This strain also has immunomodulatory effects, enhancing the host's immune response by promoting the production of anti-inflammatory cytokines and increasing the activity of immune cells.

Pharmacodynamics

The pharmacodynamics of Bifidobacterium longum involve its ability to balance the gut microbiome, enhance mucosal immunity, and improve intestinal permeability. It has been shown to lower the pH of the gut, creating an unfavorable environment for pathogenic organisms. Additionally, it can alleviate symptoms associated with gastrointestinal disorders such as irritable bowel syndrome (IBS), diarrhea, and constipation by promoting regular bowel movements and reducing inflammation in the gut.

Pharmacokinetics

Bifidobacterium longum is not absorbed into the systemic circulation but acts locally within the gastrointestinal tract. Its effects are primarily exerted in the intestines, where it colonizes and interacts with the gut environment. The survival and efficacy of this probiotic can be influenced by factors such as the formulation, dosage, and the individual's existing gut microbiota. Generally, ingestion of probiotics leads to transient colonization, with the bacteria being excreted in feces within a few days after discontinuation of use.

Pregnancy

Safety during pregnancy has not been established. Consult healthcare professionals before use.

Breast-feeding

Safety during breastfeeding has not been established. Consult healthcare professionals before use.

Storage

Store in a cool, dry place, away from direct sunlight and moisture.

Indications

• Uncomplicated malaria caused by Plasmodium falciparum

Dosage

Children: Refer to the BNF for Children for appropriate dosing in paediatric patients.

Adults: Refer to the BNF for specific dosing recommendations.

Mechanism of action

Piperaquine acts by interfering with the heme detoxification process in the malaria parasite. It accumulates within the food vacuole of the parasite and inhibits the conversion of toxic heme into non-toxic hemozoin. This accumulation of free heme leads to oxidative stress and cellular damage, ultimately resulting in the death of the parasite.

Pharmacodynamics

Piperaquine demonstrates a dose-dependent response in its antimalarial activity. It is effective against the asexual blood stages of Plasmodium species, with a prolonged half-life that allows for once-weekly dosing in some regimens. The drug's efficacy is influenced by the rate of parasite clearance and the patient's immune response.

Pharmacokinetics

Piperaquine is well-absorbed following oral administration, with peak plasma concentrations typically occurring within 4 to 6 hours. It has a long elimination half-life, which can range from 10 to 30 days, allowing for sustained plasma levels. The drug is metabolized in the liver and excreted primarily in the feces, with a smaller fraction eliminated in the urine. Its pharmacokinetics can be significantly affected by drug interactions, particularly those that alter hepatic metabolism.

Interactions

• grapefruit juice: Severe (increases concentration)
• mitotane: Severe (decreases concentration)
• St. John's wort: Severe (decreases concentration)
• rifampicin: Severe (decreases concentration)
• dronedarone: Unknown (increases concentration)
• cobicistat: Unknown (increases concentration)
• crizotinib: Unknown (increases concentration)
• idelalisib: Unknown (increases concentration)
• imatinib: Unknown (increases concentration)
• letermovir: Unknown (increases concentration)

Pregnancy

Consult with a healthcare professional regarding the use of piper during pregnancy.

Breast-feeding

Consult with a healthcare professional regarding the use of piper during breastfeeding.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• {'name': 'Piperaquine', 'class': 'Penicillins', 'molecular_formula': 'C38H36N4O4'}

Indications

• Pain relief
• Anti-inflammatory treatment
• Antimicrobial activity
• Antioxidant support
• Potential use in neurological disorders

Dosage

Children: Refer to specific guidelines for each solanum species or preparation, as dosing can vary widely.

Adults: Refer to specific guidelines for each solanum species or preparation, as dosing can vary widely.

Mechanism of action

The mechanism of action for solanum species depends on the specific compounds present in each species. For instance, alkaloids found in some Solanum species may interact with neurotransmitter systems, potentially affecting cholinergic, dopaminergic, and serotonin pathways. Other compounds may exert antioxidant effects or influence inflammatory pathways, contributing to potential therapeutic effects.

Pharmacodynamics

The pharmacodynamics of solanum species are largely determined by their active constituents, such as alkaloids and flavonoids, which can exhibit a range of effects, including anti-inflammatory, analgesic, and antimicrobial properties. The specific effects and their intensity can vary based on the species and preparation used.

Pharmacokinetics

Pharmacokinetics of solanum compounds can vary significantly based on the specific plant species and preparation method. Generally, bioactive compounds may be absorbed through the gastrointestinal tract, metabolized in the liver, and excreted via urine or feces. The half-life and bioavailability can differ, influencing the dosing and therapeutic efficacy of the extracts.

Adverse effects

• Gastrointestinal disturbances
• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Neurological symptoms (in cases of toxicity)

Precautions

• Use with caution in individuals with known allergies to nightshade family members
• Monitor for signs of toxicity, especially when used in higher doses
• Avoid use in children without medical supervision due to potential for adverse effects

Pregnancy

Safety during pregnancy has not been established. Use only if clearly needed and prescribed by a healthcare provider.

Breast-feeding

Caution is advised as safety during breastfeeding has not been established.

Storage

Store in a cool, dry place away from light and moisture. Keep out of reach of children.

Formulations

• Dried leaves
• Powdered extracts
• Tinctures

Indications

• Asthma
• Chronic bronchitis
• Cough
• Respiratory tract infections

Dosage

Children: Refer to relevant clinical guidelines and herbal medicine references for appropriate dosing information.

Adults: Refer to relevant clinical guidelines and herbal medicine references for appropriate dosing information.

Mechanism of action

The mechanism of action of vasicine involves the inhibition of inflammatory mediators and the relaxation of bronchial smooth muscle. This results in bronchodilation, which helps alleviate symptoms of bronchospasm. Additionally, vasicine has been shown to possess antitussive properties, reducing cough and promoting the expulsion of mucus from the respiratory tract.

Pharmacodynamics

Vasica exhibits anti-inflammatory, bronchodilator, and expectorant effects. Its active compounds facilitate the relaxation of the bronchial muscles, enhance mucociliary clearance, and suppress cough reflexes. The pharmacological actions contribute to improved airway patency and respiratory function in patients with obstructive airway diseases.

Pharmacokinetics

The pharmacokinetics of vasicine include its absorption, distribution, metabolism, and excretion, though specific data on its pharmacokinetic profile are limited. Vasicine is likely absorbed through the gastrointestinal tract and may undergo hepatic metabolism. Its elimination half-life and specific metabolic pathways have not been extensively studied, warranting further research to fully elucidate these aspects.

Adverse effects

• Gastrointestinal disturbances
• Nausea
• Vomiting
• Headache
• Allergic reactions

Precautions

• Monitor for allergic reactions in patients with a history of hypersensitivity
• Use with caution in patients with gastrointestinal disorders

Pregnancy

Safety during pregnancy has not been established. Use only if clearly needed and after assessing risks versus benefits.

Breast-feeding

It is unknown whether vasica is excreted in human milk. Caution is advised when administering to breastfeeding women.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Oral tablets
• Liquid extract
• Syrup

Indications

• Anti-inflammatory conditions
• Pain management
• Fever reduction
• Antimicrobial treatment

Dosage

Children: Dosage in children should be determined by a healthcare provider, taking into consideration age, weight, and specific condition.

Adults: Dosage varies based on the formulation and condition being treated. Refer to specific herbal preparation guidelines or consult a healthcare provider.

Mechanism of action

The mechanism of action of Xanthocarpum is not fully understood, but it is believed that the active phytochemicals may exert their effects through modulation of inflammatory pathways and inhibition of cyclooxygenase and lipoxygenase enzymes. These actions can lead to a reduction in pain and inflammation, as well as possible antipyretic effects by influencing the hypothalamic heat-regulating center.

Pharmacodynamics

Xanthocarpum displays a range of pharmacodynamic effects, including anti-inflammatory and analgesic properties. The flavonoids found in the plant may have antioxidant effects, scavenging free radicals and reducing oxidative stress. Additionally, the plant may exhibit potential antimicrobial activity, contributing to its traditional use in treating infections.

Pharmacokinetics

The pharmacokinetics of Xanthocarpum are not well documented. However, it is generally understood that the absorption, distribution, metabolism, and excretion of phytochemicals can vary widely based on their chemical structures and the formulation used. Bioavailability may be influenced by factors such as the presence of other compounds in herbal preparations and individual patient characteristics.

Pregnancy

The safety of xanthocarpum during pregnancy has not been established. It is advisable to avoid use unless clearly needed.

Breast-feeding

The excretion of xanthocarpum in human milk is unknown. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Mechanism of action

Curcumin acts as a scavenger of oxygen species, such as hydroxyl radical, superoxide anion, and singlet oxygen and inhibit lipid peroxidation as well as peroxide-induced DNA damage. Curcumin mediates potent anti-inflammatory agent and anti-carcinogenic actions via modulating various signalling molecules. It suppresses a number of key elements in cellular signal transduction pathways pertinent to growth, differentiation, and malignant transformation; it was demonstrated _in vitro_ that curcumin inhibits protein kinases, c-Jun/AP-1 activation, prostaglandin biosynthesis, and the activity and expression of the enzyme cyclooxygenase (COX)-2. Curcumin, a polyphenolic natural product, exhibits therapeutic activity against a number of diseases, attributed mainly to its chemical structure and unique physical, chemical, and biological properties. It is a diferuloyl methane molecule [1,7-bis (4-hydroxy-3- methoxyphenyl)-1,6-heptadiene-3,5-dione)] containing two ferulic acid residues joined by a methylene bridge. It has three important functionalities: an aromatic o-methoxy phenolic group, alpha, beta-unsaturated beta-diketo moiety and a seven carbon linker. Extensive research in the last two decades has provided evidence for the role of these different functional groups in its crucial biological activities. A few highlights of chemical structural features associated with the biological activity of curcumin are: The o-methoxyphenol group and methylenic hydrogen are responsible for the antioxidant activity of curcumin, and curcumin donates an electron/ hydrogen atom to reactive oxygen species. Curcumin interacts with a number of biomolecules through non-covalent and covalent binding. The hydrogen bonding and hydrophobicity of curcumin, arising from the aromatic and tautomeric structures along with the flexibility of the linker group are responsible for the non-covalent interactions. The alpha, beta-unsaturated beta-diketone moiety covalently interacts with protein thiols, through Michael reaction. The beta-diketo group forms chelates with transition metals, thereby reducing the metal induced toxicity and some of the metal complexes exhibit improved antioxidant activity as enzyme mimics. New analogues with improved activity are being developed with modifications on specific functional groups of curcumin... The present study demonstrates that curcumin acts as pro-oxidant and sensitizes human lung adenocarcinoma epithelial cells (A549) to apoptosis via intracellular redox status mediated pathway. Results indicated that curcumin induced cell toxicity (light microscopy and MTT assay) and apoptosis (AnnexinV-FITC/PI labeling and caspase-3 activity) in these cells. These events seem to be mediated through generation of reactive oxygen species (ROS) and superoxide radicals (SOR) and enhanced levels of lipid peroxidation. These changes were accompanied by increase in oxidized glutathione (GSSG), reduced glutathione (GSH) and gamma-glutamylcysteine synthetase (gamma-GCS) activity, but decrease in GSH/GSSG ratio. The induction of apoptosis and decrease in GSH/GSSG ratio was also accompanied by sustained phosphorylation and activation of p38 mitogen activated protein kinase (MAPK). On the other hand, addition of N-acetyl cysteine (NAC), an antioxidant, blocked the curcumin-induced ROS production and rescued malignant cells from curcumin-induced apoptosis through caspase-3 deactivation. However, L-buthionine sulfoximine (BSO), a GSH synthesis blocking agent, further enhanced curcumin-induced ROS production and apoptosis in A549 cells. Decreased GSH/GSSG ratio seems to be a crucial factor for the activation of MAPK signaling cascade by curcumin. The study therefore, provides an insight into the molecular mechanism involved in sensitization of lung adenocarcinoma cells to apoptosis by curcumin. Curcumin has many pharmaceutical applications, many of which arise from its potent antioxidant properties. The present research examined the antioxidant activiti

Pharmacodynamics

Intravenous application of 25 mg/kg bw curcumin to rats resulted in an increase in bile flow by 80 and 120%. In the rat model of inflammation, curcumin was shown to inhibit edema formation. In nude mouse that had been injected subcutaneously with prostate cancer cells, administration of curcumin caused a marked decrease in the extent of cell proliferation, a significant increase of apoptosis and micro-vessel density. Curcumin may exert choleretic effects by increasing biliary excretion of bile salts, cholesterol, and bilirubin, as well as increasing bile solubility. Curcumin inhibited arachidonic acid-induced platelet aggregation _in vitro_.